Bacteriology Research Scientist A

Cape Fox subsidiary Eagle Health, LLC is accepting resumes for a Bacteriology Research Scientistto support the members at Ft. Detrick, Maryland. This position is contingent upon contract award.

Incumbents are encouraged to apply!

The salary range (or hiring range) for this exempt position has been established at: $74,000-$82,000.

The above salary range represents the company's good faith and reasonable estimate of the range of possible compensation at the time of posting. In addition, we offer a variety of benefits including company holidays, paid time off, health insurance, dental insurance, vision insurance, life and disability insurance, tuition reimbursement, as well as 401K with company match. This job will be posted until filled or withdrawn.

Responsibilities:

The employee shall serve as Research Scientist conducting and assisting in basic and applied research on specified bacterial threats in support of the BD and infectious disease program. This includes planning and execution of scientific studies, performing bacterial assays and animal procedures, data collection and analyzing, manuscript development, and maintaining laboratory space and equipment. The candidate should have a Ph.D. or D.V.M and two years' research experience (or M.S. degree with 7 years relevant research experience) in the fields of bacteriology, animal physiology, oganoids/microphysiological systems that recapitulate animal models of infectious diseases, or similar field of research. The candidate should also have demonstrated successes in designing, executing, and analyzing all stages of complex studies including regulatory requirements associated with the FDA-animal rule. Experience working in high containment (BSL-3 and ABSL-3) is preferred. The candidate shall work in BSL-3 laboratories and handle controlled substances thus shall hold and maintain BPRP and CS-PRP status, IAW the provisions in this contract and applicable regulations.

Shall assist in planning, managing, and executing complex in vitro studies using various organoids/organ-on-a-chip or other microphysiological system to recapitulate data observed using animal models of infectious diseases. These studies will focus on the bacterial pathogenesis of and development of medical countermeasures against the diseases plague, tularemia, melioidosis, glanders, anthrax, and Q-fever and will be performed under BSL-2 and BSL-3 condition depending upon the experimental goals. In these types of studies, extreme attention to detail while working under high-containment conditions is essential.

• Shall assist in planning, managing, and executing complex in vitro studies using various organoids/organ-on-a-chip or other microphysiological system to recapitulate data observed using animal models of infectious diseases. These studies will focus on the bacterial pathogenesis of and development of medical countermeasures against the diseases plague, tularemia, melioidosis, glanders, anthrax, and Q-fever and will be performed under BSL-2 and BSL-3 condition depending upon the experimental goals. In these types of studies, extreme attention to detail while working under high-containment conditions is essential.
• Shall perform animal manipulations to include but not limited to observations, injections, blood draws, and euthanasia on laboratory animals (to include non-human primates) under ABSL-2 and ABSL-3 conditions.
• Shall collate, analyze, and draft contributing scientist reports on clinical readout of disease (i.e. radiographs, clinical chemistry, and hematology) of non-human primates.
• Shall draft up to seven animal protocols, study protocols, and/or technical reports annually.
• Shall assist in drafting at least one peer-reviewed manuscript annually.
• Shall maintain a GLP training folder and be compliant with all GLP regulations when applicable.
• Shall review, organize, and analyze study paperwork and data generated for at least four studies per year.
• Shall work in a BSL-2 and BSL-3 laboratory performing in vitro assays (i.e. bacterial propagation, bacterial burden enumeration, and PCR) in support of the funded research portfolio. Bacteria may include, but are not limited to Francisella tularensis, Yersinia pestis, Bacillus anthracis, Coxiella burnetii, Burkholderia pseudomallei, and Burkholderia mallei.
• Shall assist in managing, designing, and executing co-infection in vivo studies that may include multiple species of bacteria or a bacterium and a virus, including the establishment of new procedures and drafting animal care and use protocols.
• Shall perform and assist managing routine laboratory maintenance and sustainment activities in both BSL-2 and BSL-3 safety levels.
• Shall maintain accountability of all BSAT and IAT, ensure records are up to date, and timely communicated to the FSAP-registered PI.
• Shall perform quality review on all raw data and ensure corrections are made under good documentation practices.
• Shall review relevant literature monthly. May assist in the preparation standard operating procedures. May be expected to present research findings at one scientific conference per year, which may require CONUS or OCONUS travel. Shall present results in written and oral format publicly and internally as requested.
• Shall provide 1 Bacteriology Research Scientist monthly report to the TPOC by the last working day of the month. Report will include materials and methods, data and data analysis and should be updated monthly.
• CS-PRP enrollment is required and shall be held and maintained IAW the provisions in this contract and all applicable regulations.
• BPRP enrollment is required and shall be held and maintained IAW the provisions in this contract and all applicable regulations.

Cape Fox Corporation, its subsidiaries, and affiliates provide equal employment opportunities to all persons and prohibit employment decisions on the basis of race, religion, color, creed, national origin, sex, age, disability, political affiliation, protected veteran status, or sexual orientation, or any other characteristic protected by federal, state, or local law. Cape Fox Corporation, its subsidiaries, and affiliates offer preference to Cape Fox Corporation Shareholders, descendants, and other Native Americans pursuant to Public Law 100-241.